New Clinical Products: A Pre-Purchase Medical Waste Review Checklist

A product trial usually asks whether a new clinical supply works well, fits the budget, and is easy to use. Add one more question before approving the purchase: what happens to every component after use? A new injection device, treatment kit, or diagnostic supply can change your waste stream even when patient volume stays the same. RedBags recommends making disposal planning part of product evaluation, rather than discovering a mismatch after boxes arrive.

1. Map the product from package to discard

Ask the clinical team to walk through a representative use with an unused demonstration unit. List the outer packaging, protective caps, applicators, medication residues, disposable attachments, and anything left in the device. Record which pieces become contaminated during the procedure and which remain clean. Keep real used materials out of purchasing meetings and demonstrations.

Do not assume that everything supplied in one kit belongs in one disposal container. Equally, do not plan to dismantle a used device simply to recover recyclable material. Review manufacturer instructions and ask infection prevention or occupational safety personnel whether the proposed workflow introduces avoidable handling.

2. Resolve the classification before ordering

Identify the person who will approve the waste determination. Depending on the product, that review may involve pharmacy, environmental health and safety, infection prevention, or a qualified regulatory adviser. Separate questions about infectious contamination from questions about chemical hazards, drug residues, batteries, or other components. A familiar-looking device can still need a different disposal pathway.

EPA explains that medical waste is primarily regulated by state environmental and health departments. Therefore, a supplier’s general disposal statement is not a substitute for checking the rules that apply where your facility operates. Confirm the classification and the proposed receiving facility’s acceptance conditions before committing to volume purchases.

3. Test container fit without creating exposure

Use clean demonstration materials to evaluate the entire discarded configuration. Check whether a larger device fits the intended container opening without forcing, bending, or removing safety features. Consider how quickly the new product would consume usable capacity. Never use a trial as permission to overfill containers or retrieve items from a waste receptacle.

For workplaces covered by OSHA’s Bloodborne Pathogens standard, contaminated sharps must be discarded into containers meeting specified requirements, including being closable, puncture resistant, and leakproof on the sides and bottom. Sharps containers must be replaced routinely and not allowed to overfill. A successful product trial must preserve those protections.

4. Give the trial a written approval gate

Before expanding the purchase, collect a short decision record:

• Product name, version, and components evaluated.
• Approved disposal pathway for each relevant component.
• Container fit, placement, and capacity observations.
• Written answers to unresolved acceptance or handling questions.
• Named approver, staff instruction owner, and launch date.

Keep approval conditional if key questions remain unanswered. Purchasing staff should know who can pause an order when the disposal plan is incomplete. This is an internal control, not a claim that every product requires a special government approval.

5. Recheck the first routine deliveries

Confirm that delivered supplies match the version evaluated. After rollout, ask frontline staff whether the planned container and disposal steps actually work during normal care. Investigate unexpected volume or handling difficulties without opening waste containers to sort their contents. Document changes before the next purchasing cycle. RedBags can be part of the service-planning conversation while your facility retains responsibility for its own product and waste decisions.